Nevirapine-associated toxicity in Niger

HIV Medicine

Volumn 9, Issue 1, 2008, Pages 62-63

  Meyssonnier, V ^a   Costagliola, D ^b   Caumes, Pr E ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

ADULT; AGE DISTRIBUTION; AMINOTRANSFERASE BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ERUPTION; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; LETTER; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NIGER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PRURITUS; RISK FACTOR; SEX DIFFERENCE; SKIN MANIFESTATION;

ADULT; ANTI-HIV AGENTS; EPIDEMIOLOGIC METHODS; EXANTHEMA; FEMALE; HEPATITIS, TOXIC; HIV INFECTIONS; HIV-1; HUMANS; LIVER; MALE; NEVIRAPINE; NIGER; PRURITUS; SKIN;

EID: 38349025442     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00516.x     Document Type: Letter

References (6)

1. Phanuphak N, Apornpong T, Teeratakulpisarn S et al. Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women. HIV Med 2007; 8: 357-366.
2. Caumes E, Bossi P, Katlama C, Bricaire F. Antiretroviral-induced toxiderma in HIV-infected patients. Presse Med 2003; 32: 1325-1333.
3. Forna F, Liechty CA, Solberg P et al. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J AIDS 2007; 44: 456-462.
4. Dieterich DT. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis 2004; 38: 80-89.
5. Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L. Generic fixed-dose combination multiretroviral treatment in resource-poor settings: Multicentric observational cohort. AIDS 2006; 20: 1163-1169.
6. Sabin SA. Pitfalls of assessing hepatotoxicity in trials and observational cohorts. Clin Infect Dis 2004; 38: 56-64.